BE2012C053I2 - - Google Patents

Download PDF

Info

Publication number
BE2012C053I2
BE2012C053I2 BE2012C053C BE2012C053C BE2012C053I2 BE 2012C053 I2 BE2012C053 I2 BE 2012C053I2 BE 2012C053 C BE2012C053 C BE 2012C053C BE 2012C053 C BE2012C053 C BE 2012C053C BE 2012C053 I2 BE2012C053 I2 BE 2012C053I2
Authority
BE
Belgium
Application number
BE2012C053C
Other languages
French (fr)
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of BE2012C053I2 publication Critical patent/BE2012C053I2/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE2012C053C 2003-05-14 2012-12-17 BE2012C053I2 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47047103P 2003-05-14 2003-05-14

Publications (1)

Publication Number Publication Date
BE2012C053I2 true BE2012C053I2 (da) 2023-08-09

Family

ID=33476714

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2012C053C BE2012C053I2 (da) 2003-05-14 2012-12-17

Country Status (28)

Country Link
US (2) US7357935B2 (da)
EP (1) EP1622642B1 (da)
JP (2) JP5334029B2 (da)
KR (1) KR101106024B1 (da)
CN (1) CN100387299C (da)
AR (1) AR044338A1 (da)
AT (1) ATE380557T1 (da)
AU (1) AU2004240584B2 (da)
BE (1) BE2012C053I2 (da)
BR (1) BRPI0410332B1 (da)
CA (1) CA2524942C (da)
CO (1) CO5640040A2 (da)
CY (1) CY1107188T1 (da)
DE (1) DE602004010643T2 (da)
DK (1) DK1622642T3 (da)
ES (1) ES2297448T3 (da)
FR (1) FR12C0073I2 (da)
HK (1) HK1083597A1 (da)
HR (1) HRP20080069T3 (da)
HU (1) HUS1200029I1 (da)
MX (1) MXPA05012218A (da)
NZ (1) NZ543559A (da)
PL (1) PL1622642T3 (da)
PT (1) PT1622642E (da)
SI (1) SI1622642T1 (da)
TW (1) TW200505475A (da)
WO (1) WO2004103402A1 (da)
ZA (1) ZA200509979B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297338B2 (en) * 2003-05-14 2007-11-20 Wyeth Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella
CN101575586B (zh) * 2009-05-31 2011-01-19 华中农业大学 一种支气管败血波氏杆菌基因缺失疫苗及应用
KR101321501B1 (ko) * 2011-09-21 2013-10-29 주식회사 바이오포아 조류 대장균증 백신 조성물 및 이의 제조방법
BRPI1105176A2 (pt) * 2011-11-22 2013-09-10 Unicamp linhagens de escherichia coli, atenuadas para septicemia em aves, vacinas produzidas com essas linhagensm, metodo de produÇço de vacinas e seus usos
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
CN106465698A (zh) * 2016-09-24 2017-03-01 王德 一种预防雏鸡大肠杆菌病的方法
CN106987549B (zh) * 2017-04-26 2020-08-21 河北科星药业有限公司 培养基及相应的预防禽类大肠杆菌病的广谱菌苗的生产方法
KR20190070457A (ko) 2017-12-13 2019-06-21 주식회사 오투파워 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물
CN112442473B (zh) * 2020-12-02 2022-10-25 青岛易邦生物工程有限公司 一种禽大肠杆菌疫苗株
CN112494641B (zh) * 2020-12-02 2022-07-05 青岛易邦生物工程有限公司 一种禽大肠杆菌活疫苗
CN112695004A (zh) * 2020-12-28 2021-04-23 南通大学 APEC双基因rpoS和arcA缺失菌株及弱毒疫苗
EP4252770A1 (en) 2022-04-01 2023-10-04 Veterinärmedizinische Universität Wien Composition comprising irradiated e. coli
CN116024151B (zh) * 2022-12-13 2024-01-26 南通大学 一种禽致病性大肠杆菌sRNA s078基因缺失菌株及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040958B1 (en) 1980-05-26 1984-03-14 Ici Australia Limited Process for the synthesis of gamma-unsaturated carboxylic acid esters
JPH085802B2 (ja) 1986-08-13 1996-01-24 日清製粉株式会社 家禽大腸菌症ワクチン
GB8912330D0 (en) 1989-05-30 1989-07-12 Wellcome Found Live vaccines
US5641491A (en) 1993-06-15 1997-06-24 The Penn State Research Foundation Escherichia coli strain 364 and use of said strain as a vaccine
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ(in ovo)ワクチン
EP0973865A2 (en) * 1997-04-11 2000-01-26 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Attenuated, invasive vaccines against fish pathogens
GB9806449D0 (en) 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
US7297338B2 (en) 2003-05-14 2007-11-20 Wyeth Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella

Also Published As

Publication number Publication date
CY1107188T1 (el) 2012-10-24
ZA200509979B (en) 2008-11-26
HK1083597A1 (en) 2006-07-07
AU2004240584B2 (en) 2010-01-07
EP1622642A1 (en) 2006-02-08
BRPI0410332B1 (pt) 2019-10-08
SI1622642T1 (sl) 2008-04-30
CN100387299C (zh) 2008-05-14
DK1622642T3 (da) 2008-03-25
US20040234534A1 (en) 2004-11-25
US7575754B2 (en) 2009-08-18
KR101106024B1 (ko) 2012-01-17
WO2004103402A1 (en) 2004-12-02
CA2524942C (en) 2012-10-23
US7357935B2 (en) 2008-04-15
NZ543559A (en) 2008-02-29
DE602004010643T2 (de) 2008-12-04
PL1622642T3 (pl) 2008-03-31
FR12C0073I2 (fr) 2013-08-16
AU2004240584A1 (en) 2004-12-02
MXPA05012218A (es) 2006-02-08
CO5640040A2 (es) 2006-05-31
BRPI0410332A (pt) 2006-05-30
TW200505475A (en) 2005-02-16
AR044338A1 (es) 2005-09-07
FR12C0073I1 (da) 2013-01-18
CA2524942A1 (en) 2004-12-02
US20080213317A1 (en) 2008-09-04
EP1622642B1 (en) 2007-12-12
HRP20080069T3 (en) 2008-03-31
JP5334029B2 (ja) 2013-11-06
DE602004010643D1 (de) 2008-01-24
PT1622642E (pt) 2008-02-18
HUS1200029I1 (hu) 2017-02-21
ES2297448T3 (es) 2008-05-01
JP2007500745A (ja) 2007-01-18
CN1822855A (zh) 2006-08-23
ATE380557T1 (de) 2007-12-15
KR20060012612A (ko) 2006-02-08
JP2011234721A (ja) 2011-11-24

Similar Documents

Publication Publication Date Title
BE2014C055I2 (da)
BE2014C027I2 (da)
BE2014C003I2 (da)
BE2013C075I2 (da)
BE2013C069I2 (da)
BE2013C067I2 (da)
BE2013C038I2 (da)
BE2013C036I2 (da)
BE2013C034I2 (da)
BE2011C030I2 (da)
JP2004065983A5 (da)
JP2003256726A5 (da)
JP2004169918A5 (da)
JP2004055126A5 (da)
BE2015C005I2 (da)
BE2012C053I2 (da)
IN2006CH01927A (da)
JP2004015807A5 (da)
JP2003249721A5 (da)
JP2004056761A5 (da)
JP2004098283A5 (da)
JP2003263271A5 (da)
JP2003266795A5 (da)
JP2004126536A5 (da)
JP2004223600A5 (da)